Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'19
Mar'18
Mar'17
Net Sales
103.84
72.84
61.74
50.05
35.35
29.62
24.49
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
103.84
72.84
61.74
50.05
35.35
29.62
24.49
Raw Material Cost
74.85
51.13
46.14
37.75
28.14
24.69
21.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
1.09
0.92
1.30
0.48
0.27
0.39
0.31
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.49
1.52
1.20
1.20
0.40
0.69
0.64
Selling and Distribution Expenses
11.15
5.93
5.39
3.53
2.82
1.62
1.04
Other Expenses
-2.58
3.05
-0.89
0.35
0.53
-0.33
-0.18
Total Expenditure (Excl Depreciation)
86.00
62.54
53.14
43.30
32.15
27.06
23.31
Operating Profit (PBDIT) excl Other Income
17.84
10.30
8.60
6.75
3.20
2.56
1.17
Other Income
0.18
0.19
0.02
0.18
0.01
0.22
0.07
Operating Profit (PBDIT)
19.12
11.12
9.41
7.13
3.46
2.90
1.30
Interest
1.49
1.52
1.20
1.20
0.40
0.69
0.64
Exceptional Items
0.00
0.00
0.00
0.00
-0.00
0.00
0.00
Gross Profit (PBDT)
28.99
21.71
15.60
12.30
7.21
4.93
2.98
Depreciation
1.10
0.80
0.83
0.44
0.25
0.17
0.15
Profit Before Tax
16.53
8.80
7.39
5.49
2.81
2.04
0.52
Tax
0.26
0.55
0.15
0.25
0.72
0.59
0.13
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
16.27
8.25
7.24
5.24
2.09
1.45
0.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
16.27
8.25
7.24
5.24
2.09
1.45
0.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
16.27
8.25
7.24
5.24
2.09
1.45
0.39
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
78.52
62.75
54.50
38.88
13.91
4.94
3.49
Earnings per share (EPS)
8.12
4.12
3.75
4.28
1.48
1.41
0.88
Diluted Earnings per share
8.12
4.12
3.75
4.28
1.48
1.41
0.88
Operating Profit Margin (Excl OI)
17.18%
13.9%
13.88%
13.0%
9.03%
8.47%
4.46%
Gross Profit Margin
16.98%
13.19%
13.3%
11.84%
8.67%
7.46%
2.73%
PAT Margin
15.67%
11.33%
11.73%
10.46%
5.91%
4.89%
1.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 42.56% vs 17.98% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 97.21% vs 13.95% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 73.19% vs 16.40% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -1.97% vs 26.67% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Indo US Bio-Tech With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
103.84
1,003.95
-900.11
-89.66%
Other Operating Income
0.00
0.00
0.00
Total Operating income
103.84
1,003.95
-900.11
-89.66%
Raw Material Cost
74.85
763.88
-689.03
-90.20%
Purchase of Finished goods
0
13.74
-13.74
-100.00%
(Increase) / Decrease In Stocks
0
0.05
-0.05
-100.00%
Employee Cost
1.09
70.23
-69.14
-98.45%
Power Cost
0
0.00
0.00
Manufacturing Expenses
1.49
0.00
1.49
Selling and Distribution Expenses
11.15
0.00
11.15
Other Expenses
-2.58
167.29
-169.87
-101.54%
Total Expenditure (Excl Depreciation)
86.00
1,015.19
-929.19
-91.53%
Operating Profit (PBDIT) excl Other Income
17.84
-11.24
29.08
258.72%
Other Income
0.18
32.33
-32.15
-99.44%
Operating Profit (PBDIT)
19.12
21.09
-1.97
-9.34%
Interest
1.49
19.23
-17.74
-92.25%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
28.99
1.86
27.13
1,458.60%
Depreciation
1.10
19.41
-18.31
-94.33%
Profit Before Tax
16.53
-17.55
34.08
194.19%
Tax
0.26
-2.23
2.49
111.66%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
16.27
-15.32
31.59
206.20%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0.00
0.00
Other Adjustments
0
0.00
0.00
Net Profit
16.27
-15.32
31.59
206.20%
Share in Profit of Associates
0
4.22
-4.22
-100.00%
Minority Interest
0.00
-0.11
0.11
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
16.27
-11.21
27.48
245.14%
Equity Capital
0
3.16
-3.16
-100.00%
Face Value
10.00
5.00
0.00
Reserves
78.52
88.35
-9.83
-11.13%
Earnings per share (EPS)
8.12
-4.43
12.55
283.30%
Diluted Earnings per share
8.12
-4.43
12.55
283.30%
Operating Profit Margin (Excl OI)
17.18%
-1.12%
0.00
18.30%
Gross Profit Margin
16.98%
0.19%
0.00
16.79%
PAT Margin
15.67%
-1.11%
0.00
16.78%
Public Share Holdings (%)
0%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 103.84 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 42.56% vs 17.98% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 16.27 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 97.21% vs 13.95% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 18.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 73.19% vs 16.40% in Mar 2024
Annual - Interest
Interest 1.49 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -1.97% vs 26.67% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.18%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
